CAD 0.56
(3.7%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | 7.79 Million USD | 112.84% |
2022 | -60.68 Million USD | -198.13% |
2021 | -20.35 Million USD | -141.7% |
2020 | -8.42 Million USD | 72.54% |
2019 | -30.67 Million CAD | 0.0% |
2017 | -142.51 Thousand CAD | -34.45% |
2016 | -106 Thousand USD | 68.62% |
2015 | -337.75 Thousand USD | 64.53% |
2014 | -952.32 Thousand CAD | 36.39% |
2013 | -1.49 Million CAD | 5.42% |
2012 | -1.58 Million CAD | 53.43% |
2011 | -3.39 Million CAD | -69.19% |
2010 | -2 Million CAD | -7448.2% |
2009 | -26.61 Thousand CAD | 28.31% |
2008 | -37.12 Thousand CAD | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q2 | 8.4 Million USD | 104.03% |
2024 Q1 | 4.11 Million USD | 52.32% |
2023 FY | 7.79 Million USD | 112.84% |
2023 Q3 | 2.82 Million USD | -16.88% |
2023 Q2 | 3.4 Million USD | 288.89% |
2023 Q1 | -1.8 Million USD | 89.51% |
2023 Q4 | 2.7 Million USD | -4.31% |
2022 Q4 | -17.16 Million USD | -33.58% |
2022 Q2 | -11.99 Million USD | -36.21% |
2022 Q1 | -8.8 Million USD | 44.35% |
2022 FY | -60.68 Million USD | -198.13% |
2022 Q3 | -12.84 Million USD | -7.09% |
2021 Q2 | -3.4 Million USD | -209.26% |
2021 Q1 | -1.1 Million USD | -166.63% |
2021 Q4 | -15.82 Million USD | -10244.44% |
2021 Q3 | -153 Thousand USD | 95.51% |
2021 FY | -20.35 Million USD | -141.7% |
2020 FY | -8.42 Million USD | 72.54% |
2020 Q1 | -7.49 Million USD | 7.8% |
2020 Q2 | -3.71 Million USD | 50.45% |
2020 Q3 | 319 Thousand USD | 108.59% |
2020 Q4 | 1.65 Million USD | 418.5% |
2019 Q3 | -3.6 Million CAD | 68.85% |
2019 Q2 | -11.58 Million CAD | -97.07% |
2019 Q4 | -8.12 Million CAD | -125.26% |
2019 FY | -30.67 Million CAD | 0.0% |
2019 Q1 | -5.87 Million CAD | -28760.87% |
2018 Q3 | -24.56 Thousand CAD | -28.23% |
2018 Q2 | -19.16 Thousand CAD | 80.34% |
2018 Q1 | -97.46 Thousand USD | -573.15% |
2018 Q4 | -20.36 Thousand CAD | 17.12% |
2017 FY | -142.51 Thousand CAD | -34.45% |
2017 Q2 | 953.10 USD | 103.25% |
2017 Q3 | -16.52 Thousand USD | -1833.59% |
2017 Q1 | -29.35 Thousand USD | -79.9% |
2017 Q4 | -14.47 Thousand USD | 12.37% |
2016 Q2 | -16.61 Thousand USD | -186.27% |
2016 Q1 | -5803.83 USD | 87.39% |
2016 Q3 | -19.05 Thousand USD | -14.68% |
2016 Q4 | -16.31 Thousand USD | 14.37% |
2016 FY | -106 Thousand USD | 68.62% |
2015 Q3 | -112.1 Thousand CAD | 40.43% |
2015 FY | -337.75 Thousand USD | 64.53% |
2015 Q4 | -46.02 Thousand CAD | 58.95% |
2015 Q2 | -188.19 Thousand CAD | -40.36% |
2015 Q1 | -134.07 Thousand CAD | 64.45% |
2014 Q4 | -377.18 Thousand CAD | -63.37% |
2014 FY | -952.32 Thousand CAD | 36.39% |
2014 Q1 | -560.43 Thousand CAD | -63.55% |
2014 Q2 | -232.02 Thousand CAD | 58.6% |
2014 Q3 | -230.87 Thousand CAD | 0.5% |
2013 Q4 | -342.67 Thousand CAD | -0.11% |
2013 FY | -1.49 Million CAD | 5.42% |
2013 Q1 | -289.83 Thousand CAD | 40.29% |
2013 Q2 | -261.71 Thousand CAD | 9.7% |
2013 Q3 | -342.3 Thousand CAD | -30.79% |
2012 Q1 | -791.95 Thousand CAD | -102.09% |
2012 Q2 | -280.26 Thousand CAD | 64.61% |
2012 FY | -1.58 Million CAD | 53.43% |
2012 Q3 | -517.16 Thousand CAD | -84.53% |
2012 Q4 | -485.36 Thousand CAD | 6.15% |
2011 Q3 | -281.8 Thousand CAD | 86.32% |
2011 Q1 | -654.96 Thousand CAD | -14.53% |
2011 Q2 | -2.05 Million CAD | -214.42% |
2011 Q4 | -391.88 Thousand CAD | -39.06% |
2011 FY | -3.39 Million CAD | -69.19% |
2010 FY | -2 Million CAD | -7448.2% |
2010 Q4 | -571.84 Thousand CAD | -57.55% |
2010 Q3 | -362.96 Thousand CAD | -720.9% |
2010 Q1 | -15.43 Thousand CAD | -109.91% |
2010 Q2 | -44.21 Thousand CAD | -186.44% |
2009 Q2 | -3149.54 CAD | 70.02% |
2009 FY | -26.61 Thousand CAD | 28.31% |
2009 Q4 | -7353.84 CAD | -81.24% |
2009 Q3 | -4057.52 CAD | -28.83% |
2009 Q1 | -10.5 Thousand CAD | -44.03% |
2008 FY | -37.12 Thousand CAD | 0.0% |
2008 Q1 | -4219.98 CAD | 0.0% |
2008 Q4 | -7293.07 CAD | -123.98% |
2008 Q3 | -3256.14 CAD | 86.56% |
2008 Q2 | -24.23 Thousand CAD | -474.25% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Aion Therapeutic Inc. | -1.19 Million CAD | 754.473% |
Ayurcann Holdings Corp. | -3.25 Million CAD | 339.764% |
Blueberries Medical Corp. | -1.22 Million CAD | 735.466% |
The BC Bud Corporation | -1.22 Million CAD | 737.072% |
BioNxt Solutions Inc. | -6.36 Million CAD | 222.413% |
CordovaCann Corp. | -2.51 Million CAD | 410.219% |
Christina Lake Cannabis Corp. | -880.54 Thousand CAD | 985.181% |
Captor Capital Corp. | 655.2 Thousand CAD | -1089.611% |
City View Green Holdings Inc. | -996.45 Thousand CAD | 882.221% |
1CM Inc. | 300.79 Thousand CAD | -2491.314% |
Global Hemp Group Inc. | -551.7 Thousand CAD | 1512.784% |
Greenway Greenhouse Cannabis Corporation | -3.87 Million CAD | 300.935% |
IM Cannabis Corp. | -12.17 Million CAD | 164.02% |
Lobe Sciences Ltd. | -3.35 Million CAD | 332.02% |
Maple Leaf Green World Inc. | -392.21 Thousand CAD | 2087.283% |
Mountain Valley MD Holdings Inc. | -3.18 Million CAD | 344.647% |
Nextleaf Solutions Ltd. | 542.27 Thousand CAD | -1337.373% |
Ovation Science Inc. | -764 Thousand CAD | 1120.204% |
Pharmadrug Inc. | -1.33 Million CAD | 683.847% |
Captiva Verde Wellness Corp. | -1.14 Million CAD | 782.54% |
RAMM Pharma Corp. | -7.08 Million CAD | 209.995% |
RIV Capital Inc. | 1.78 Million CAD | -337.832% |
Revive Therapeutics Ltd. | -3.28 Million CAD | 337.198% |
Red White & Bloom Brands Inc. | -8.76 Million CAD | 188.886% |
SLANG Worldwide Inc. | -5.98 Million CAD | 230.202% |
1933 Industries Inc. | -9.34 Million CAD | 183.369% |
Red Light Holland Corp. | -6.44 Million CAD | 220.911% |
Top Strike Resources Corp. | -784.8 Thousand CAD | 1093.173% |
Xebra Brands Ltd. | -1.55 Million CAD | 601.399% |
Adastra Holdings Ltd. | -1.79 Million CAD | 534.531% |